Prostate cancer exosomes as molecular predictors of response to therapy

Prostate cancer is the second most common cancer in men and acording to the Globocan report from 2012, there will be over 1.2 million new cases and over 300 000 deaths, worldwide. Organ-defined prostate cancer is a curable disease, but then it develops into metastatic castration resistant prostate c...

Full description

Bibliographic Details
Main Author: Fonseca, Pedro Miguel Borges (author)
Format: masterThesis
Language:eng
Published: 2016
Subjects:
Exosomes
mCRPC
Biomarkers
Resistance
Docetaxel
Abiraterone acetate
Domínio/Área Científica::Engenharia e Tecnologia::Outras Engenharias e Tecnologias
Online Access:http://hdl.handle.net/10362/17910
Country:Portugal
Oai:oai:run.unl.pt:10362/17910

Internet

http://hdl.handle.net/10362/17910

Similar Items